VistaGen Therapeutics, Inc. (VTGN)
NASDAQ·Healthcare·Biotechnology
$0.60
+4.38%
Mkt Cap $18.72M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 12, 2026 | $364.43K | $303.00K | -16.86% | -$0.51 | -$0.45 | +11.76% | — | — |
| Q4 2025 Nov 13, 2025 | $145.80K | $258.00K | +76.95% | -$0.51 | -$0.54 | -5.88% | — | — |
| Q3 2025 Aug 7, 2025 | $215.67K | $244.00K | +13.14% | -$0.47 | -$0.47 | +0.00% | — | — |
| Q2 2025 Jun 17, 2025 | $209.33K | -$15.00K | -107.17% | -$0.52 | -$0.43 | +17.31% | — | — |
| Q1 2025 Feb 13, 2025 | $182.00K | $234.00K | +28.57% | -$0.48 | -$0.46 | +4.17% | — | — |
| Q4 2024 Nov 7, 2024 | $240.00K | $183.00K | -23.75% | -$0.40 | -$0.42 | -5.00% | — | — |
| Q3 2024 Aug 13, 2024 | $300.00K | $84.00K | -72.00% | -$0.41 | -$0.35 | +14.63% | — | — |
| Q2 2024 Jun 11, 2024 | $200.00K | $197.30K | -1.35% | -$0.34 | -$0.25 | +26.47% | — | — |
| Q1 2024 Feb 13, 2024 | $200.00K | $411.40K | +105.70% | -$0.31 | -$0.22 | +29.03% | — | — |
| Q4 2023 Nov 9, 2023 | $184.60K | $278.00K | +50.60% | -$0.68 | -$0.66 | +2.94% | — | — |
| Q3 2023 Aug 10, 2023 | $180.00K | $177.00K | -1.67% | -$0.86 | -$0.94 | -9.30% | — | — |
| Q2 2023 Jun 22, 2023 | $179.60K | $175.60K | -2.23% | -$1.50 | -$1.75 | -16.67% | — | — |
| Q1 2023 Feb 7, 2023 | $90.00K | $179.60K | +99.56% | -$1.80 | -$1.50 | +16.67% | — | — |
| Q4 2022 Nov 10, 2022 | $310.05K | -$892.50K | -387.86% | -$2.40 | -$2.40 | +0.00% | — | — |
| Q3 2022 Aug 11, 2022 | $238.63K | $310.10K | +29.95% | -$2.70 | -$3.00 | -11.11% | — | — |
| Q2 2022 Jun 23, 2022 | $338.63K | $38.90K | -88.51% | -$1.80 | -$2.40 | -33.33% | — | — |
| Q1 2022 Feb 10, 2022 | $338.67K | $357.90K | +5.68% | -$2.40 | -$1.50 | +37.50% | — | — |
| Q4 2021 Nov 10, 2021 | $354.42K | $358.00K | +1.01% | -$1.50 | -$2.10 | -40.00% | — | — |
| Q3 2021 Aug 12, 2021 | $354.00K | $354.10K | +0.03% | -$1.50 | -$1.20 | +20.00% | — | — |
| Q2 2021 Jun 29, 2021 | — | $441.90K | — | -$1.50 | -$6.01 | -300.67% | — | — |